Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates strong financial performance with revenue and EBITDA exceeding guidance, and optimistic guidance for the future. Despite some concerns about claim volumes and EvolutionIQ's impact on margins, the company's strategic initiatives, such as the integration of EvolutionIQ and positive feedback on new products, are well-received. The Q&A section reveals a positive sentiment from analysts, with management providing reassuring insights on customer adoption and competitive positioning. These factors, combined with positive revenue growth and guidance, suggest a positive stock price movement.
Total Revenue $260 million, growing 12% year-over-year. Growth driven by cross-sell, upsell, adoption of new solutions, new logos, and contributions from EvolutionIQ. Industry claim volumes declined 8% year-over-year, representing a 1 percentage point headwind.
Adjusted EBITDA $108 million, up 13% year-over-year. Adjusted EBITDA margin was 42%. Growth attributed to revenue flow-through and a $2 million one-time benefit from exiting a vendor relationship.
Adjusted Gross Profit $203 million, with an adjusted gross profit margin of 78%, flat compared to the prior year. Margin stability reflects increased depreciation offset by accretion from EvolutionIQ.
Free Cash Flow $27 million, compared to $36 million in the prior year. Decline due to timing of working capital and operating losses from EvolutionIQ. Trailing 12-month free cash flow was $226 million, up 15% year-over-year.
Net Leverage 2.3x adjusted EBITDA, with $55 million in cash and $996 million in debt.
Software Gross Dollar Retention (GDR) 99%, consistent with the last 6 quarters, reflecting strong customer retention.
Software Net Dollar Retention (NDR) 107%, consistent with prior quarters. EvolutionIQ contributed approximately 1 percentage point to NDR.
AI-enabled auto physical damage (APD) solutions: Several top 10 insurers contracted for multiple AI-enabled APD solutions, extending photo AI capabilities to earlier and later stages of claim handling. These solutions cut the time to identify a total loss in half, resulting in millions of dollars in annual impact.
AI-based subrogation solution: 25 customers, including multiple top 10 insurers, are using this solution. A top 20 insurer entered a long-term agreement due to a 6:1 ROI and increased productivity.
Casualty platform: Renewals and expansions with top 10 and top 20 insurers. Integration of EvolutionIQ's Medhub into the casualty suite is generating positive engagement.
Repair facility solutions: Adoption of visual AI-based estimating solution and bill sheets tool. Bill sheets are used in over 5,000 repair facilities, achieving 20% penetration in one year.
Expansion of EvolutionIQ capabilities: Strong interest in expanding EvolutionIQ's capabilities into auto claims guidance. Renewals and expansions with top 15 disability carriers.
Repair facility adoption: Increased adoption of AI and non-AI solutions by repair facilities, including diagnostics and bill sheets.
Operational efficiency through AI: AI is being used internally to save time, reduce errors, and improve scalability, including writing code and hiring processes.
Scalable business model: Recurring revenue subscription model and scalable cloud infrastructure enable continuous investment in innovation.
Interconnected network and AI solutions: The IX Cloud architecture facilitates connectivity across a network of 35,000 businesses, enabling faster deployment of solutions and amplifying benefits.
Board of Directors update: Barak Eilam, former CEO of NICE Systems, joined the board, bringing expertise in enterprise software and AI.
Market Conditions: Industry claim volumes declined 8% year-over-year in Q2, representing a headwind to growth. This trend continues to impact revenue growth.
Competitive Pressures: The company faces challenges in maintaining its competitive edge as it relies on early adopters to drive broader market adoption of its AI-based solutions. Adoption cycles for new solutions are lengthy, which could delay revenue realization.
Regulatory Hurdles: No explicit regulatory challenges were mentioned in the transcript.
Supply Chain Disruptions: No explicit supply chain disruptions were mentioned in the transcript.
Economic Uncertainties: Geopolitical uncertainty and labor shortages were highlighted as ongoing operational challenges for clients, which could indirectly impact CCC's business.
Strategic Execution Risks: Delays in implementation of signed contracts for EvolutionIQ are impacting the timing of revenue. Additionally, the company’s reliance on a few large clients for adoption of new solutions poses a risk to achieving broader market penetration.
Revenue Guidance for Q3 2025: Expected revenue between $263 million to $266 million, representing 10% to 12% growth year-over-year.
Adjusted EBITDA Guidance for Q3 2025: Expected adjusted EBITDA of $104 million to $107 million, with a 40% adjusted EBITDA margin at the midpoint.
Full Year 2025 Revenue Guidance: Expected revenue of $1.046 billion to $1.056 billion, representing 11% year-over-year growth at the midpoint and 12% at the high end of the range.
Full Year 2025 Adjusted EBITDA Guidance: Expected adjusted EBITDA of $420 million to $428 million, with a 40% adjusted EBITDA margin at the midpoint and 41% margin at the high end of the range.
EvolutionIQ Revenue Contribution: Expected to come in at the lower end of the $45 million to $50 million guidance due to delays in implementation on signed contracts moving to production.
Stock-Based Compensation Trend: Expected to trend down as a percentage of revenue, reaching high single digits by 2027.
Share Repurchase Program: In Q2, CCC completed an open market repurchase of 11 million shares of CCC stock for $100 million. Year-to-date, the company has purchased 18 million shares for about $172 million under its previously announced $300 million share repurchase program.
The earnings call highlights positive financial performance, with strong EBITDA margins and revenue growth. The Q&A session reveals optimism regarding AI solutions, casualty business growth, and successful client wins like Liberty Mutual. Despite minor setbacks like EvolutionIQ's delayed contribution and lower gross margins, the overall sentiment remains positive due to strategic investments and operational changes. Share repurchases further enhance shareholder returns, and the guidance remains optimistic. These factors collectively indicate a likely positive stock price movement.
The earnings call summary indicates strong financial performance with revenue and EBITDA exceeding guidance, and optimistic guidance for the future. Despite some concerns about claim volumes and EvolutionIQ's impact on margins, the company's strategic initiatives, such as the integration of EvolutionIQ and positive feedback on new products, are well-received. The Q&A section reveals a positive sentiment from analysts, with management providing reassuring insights on customer adoption and competitive positioning. These factors, combined with positive revenue growth and guidance, suggest a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.